
Kynos Therapeutics – a Scottish clinical stage biopharma company focusing on developing novel kynurenine 3-monooxygenase (KMO) inhibitors – has been …

An international team of researchers have identified an “Achilles’ heel” protein that could lead to the development of novel treatments …

Researchers at the University of Edinburgh have genetically modified chickens, meaning that they lay eggs containing human proteins which can …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

